NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

RecruitingPhase 1

Sponsor: Pfizer

Conditions: Healthy Participants

Interventions: E coli vaccine 1 Dose A, E coli vaccine 1 Dose B, E coli vaccine 2, E coli vaccine 3, E coli Vaccine 4 Dose A

Countries: United States

This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.

Eligibility overview

Sex: ALL

Age: 18 Years to 64 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Ages Eligible for Study: 18 to 64 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes

Key Inclusion Criteria

1. Adult Participants \>= 18 through \< 64 years of age at the time of enrollment.
2. Healthy participants as determined by medical history, physical examination, and clinical judgement of the investigator to be eligible for inclusion in the study.

Key Exclusion Criteria

1. Severe adverse reaction history associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the study intervention(s).
2. Immunocompromised individuals with known or suspected immunodeficiency, as determined by history and/or laboratory/physical examination.
3. Women who are pregnant, plan to become pregnant during the study, or are breastfeeding.

Locations (11)

Anaheim, California, United States
Lake Forest, California, United States
Walnut Creek, California, United States
Hollywood, Florida, United States
Hollywood, Florida, United States
New York, New York, United States
Cincinnati, Ohio, United States
South Euclid, Ohio, United States
Knoxville, Tennessee, United States
Knoxville, Tennessee, United States
Maryville, Tennessee, United States